From: NEK7 promotes gastric cancer progression as a cell proliferation regulator
Characters | NEK7-high | NEK7-low | P-value |
---|---|---|---|
Status | |||
Alive | 103 | 125 | |
Dead | 85 | 62 | 0.022 |
Age | |||
Mean (SD) | 65.7 (10.3) | 65.9 (11.1) | |
Median [MIN, MAX] | 67 [35, 90] | 67.5 [39, 90] | 0.856 |
Gender | |||
Female | 71 | 63 | |
Male | 117 | 124 | 0.474 |
Race | |||
Asian | 28 | 46 | |
Black | 6 | 5 | |
White | 130 | 108 | |
Islander | 1 | 0.04 | |
pT_stage | |||
T1 | 1 | 4 | |
T1b | 2 | 10 | |
T2 | 22 | 36 | |
T2a | 6 | 3 | |
T2b | 6 | 7 | |
T3 | 78 | 90 | |
T4 | 18 | 12 | |
T4a | 33 | 13 | |
T4b | 14 | 10 | |
TX | 8 | ||
T1a | 2 | 0.003 | |
pN_stage | |||
N0 | 50 | 61 | |
N1 | 44 | 53 | |
N2 | 42 | 33 | |
N3 | 12 | 14 | |
N3a | 26 | 16 | |
N3b | 1 | 5 | |
NX | 12 | 4 | 0.058 |
pM_stage | |||
M0 | 165 | 165 | |
M1 | 12 | 13 | |
MX | 11 | 9 | 0.888 |
pTNM_stage | |||
IA | 3 | 11 | |
IB | 19 | 18 | |
II | 12 | 15 | |
IIA | 11 | 24 | |
IIB | 27 | 22 | |
IIIA | 34 | 26 | |
IIIB | 24 | 28 | |
IIIC | 24 | 11 | |
IV | 19 | 19 | |
I | 2 | ||
III | 3 | 0.036 | |
Grade | |||
G1 | 5 | 5 | |
G2 | 56 | 81 | |
G3 | 120 | 99 | |
GX | 7 | 2 | 0.025 |
New_tumor_event_type | |||
Metastasis | 31 | 23 | |
Metastasis: recurrence | 3 | 1 | |
Primary | 2 | 1 | |
Recurrence | 17 | 12 | |
Recurrence: primary | 1 | 0.907 | |
Radiation_therapy | |||
Non-radiation | 61 | 84 | |
Radiation | 25 | 19 | 0.122 |
History_of_neoadjuvant_treatment | |||
No neoadjuvant | 188 | 187 | |
Therapy_type | |||
Ancillary: chemotherapy | 19 | 13 | |
Chemotherapy | 63 | 65 | |
Chemotherapy: other. Specify in notes | 1 | ||
Chemotherapy: | 1 | ||
Chemotherapy: targeted molecular therapy | 1 | 0.406 |